1. Home
  2. LGCB vs ONCO Comparison

LGCB vs ONCO Comparison

Compare LGCB & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGCB

Linkage Global Inc

HOLD

Current Price

$1.51

Market Cap

17.1M

Sector

N/A

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$1.86

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGCB
ONCO
Founded
2011
2018
Country
Japan
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1M
2.3M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
LGCB
ONCO
Price
$1.51
$1.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.6K
376.2K
Earning Date
01-30-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.80
EPS
N/A
N/A
Revenue
N/A
$815,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.05
52 Week High
$3.10
$7.65

Technical Indicators

Market Signals
Indicator
LGCB
ONCO
Relative Strength Index (RSI) 46.85 62.34
Support Level $1.43 $0.51
Resistance Level $1.84 $3.59
Average True Range (ATR) 0.07 0.56
MACD 0.00 0.27
Stochastic Oscillator 64.29 25.77

Price Performance

Historical Comparison
LGCB
ONCO

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: